Literature DB >> 16552264

Is there still a role for triple endoscopy as part of staging for head and neck cancer?

Emmanuel Guardiola1, Loïc Chaigneau, Christian Villanueva, Xavier Pivot.   

Abstract

PURPOSE OF REVIEW: The use of tobacco and/or alcohol is linked with the occurrence of head and neck squamous cell carcinoma, esophagus cancer and lung cancer. If these carcinogenic factors can induce the development of a cancer in one of these locations, it would seem reasonable that a second cancer could appear in another of those areas, at the same time or at some point in the future. RECENT DEVELOPMENTS: This is the reason why one can consider that triple endoscopy is required as the optimal evaluation in patients with head and neck cancer. Nevertheless, the usefulness of this systematic procedure, which includes nasopharyngoscopy, laryngoscopy, pharyngoscopy, bronchoscopy and esophagoscopy, is debatable. The low number of head and neck cancers associated with synchronous primary cancers in the esophagus and/or lungs reported by several studies does not support this procedure and its morbidity. In contrast, in other studies a higher rate was observed and the authors pointed out the impact of such findings on treatment strategy, suggesting the benefit of routine triple endoscopy. One can conclude that the relevance of routine triple endoscopy is related to the rate of second synchronous primary cancer detected. A search to identify predictive factors of synchronous cancer occurrence will therefore be required.
SUMMARY: This review summarizes the available data in the literature and highlights the need for selected patients with head and neck cancer to receive triple endoscopy.

Entities:  

Mesh:

Year:  2006        PMID: 16552264     DOI: 10.1097/01.moo.0000193177.62074.fd

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  8 in total

1.  Virtual 3-D ¹⁸F-FDG PET/CT panendoscopy for assessment of the upper airways of head and neck cancer patients: a feasibility study.

Authors:  Christian Buchbender; Jon Treffert; Götz Lehnerdt; Stefan Mattheis; Bernhard Geiger; Andreas Bockisch; Michael Forsting; Gerald Antoch; Till A Heusner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-05       Impact factor: 9.236

2.  Association between hospital case volume and the use of bronchoscopy and esophagoscopy during head and neck cancer diagnostic evaluation.

Authors:  Gordon H Sun; Oluseyi Aliu; Nicholas M Moloci; Joshua K Mondschein; James F Burke; Rodney A Hayward
Journal:  Cancer       Date:  2013-09-24       Impact factor: 6.860

3.  Role of panendoscopy in identifying and managing risk of head and neck squamous cell carcinoma in routine follow-up: a retrospective clinical evaluation.

Authors:  Adrian Münscher; Susanne Sehner; Jegane Taleh; Silke Tribius; Nicolaus Möckelmann; Arne Böttcher; Amit Gulati; Carsten Dalchow; Till Clauditz; Rainald Knecht
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-07       Impact factor: 2.503

4.  Is Direct Laryngoscopy Obsolete? "Trans Nasal Oesophagoscopy" the Complete Endoscopic Solution in Head Neck Practice.

Authors:  P Lakshminarasimman; Prathamesh S Pai; Shaesta Mehta; Prachi Patil
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-01-12

5.  Risk factors for acute unplanned tracheostomy during panendoscopy in HNSCC patients.

Authors:  Friederike Eissner; Georg Haymerle; Markus Brunner
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

6.  The impact of the patient's condition, diagnostic procedures and treatment on the survival of carcinoma of unknown primary site patients.

Authors:  Karolina Dorobisz; Iwona Wlodarska-Polinska; Katarzyna Pazdro-Zastawny; Tomasz Rutkowski; Piotr Palka; Tomasz Dworzecki; Tomasz Zatonski
Journal:  Cancer Manag Res       Date:  2019-07-16       Impact factor: 3.989

7.  Value of oesophagoscopy and bronchoscopy in diagnosis of synchronous malignancies in patients with head and neck squamous cell carcinomas.

Authors:  Shi Yeung Ho; Raymond King Yin Tsang
Journal:  BMC Cancer       Date:  2020-12-01       Impact factor: 4.430

8.  Second primary tumor in patients with upper aerodigestive tract cancer.

Authors:  Antonio Vitor Martins Priante; Andre Lopes Carvalho; Luiz Paulo Kowalski
Journal:  Braz J Otorhinolaryngol       Date:  2010 Mar-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.